ANI Pharmaceuticals (ANIP) PT Lowered to $30 at Cantor Fitzgerald, Following Earnings
Tweet
Share
E-mailGet Alerts ANIP Hot Sheet
Price: $76.54 +2.37%
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
10 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Cantor Fitzgerald analyst Brandon Folkes lowered the price target on ANI Pharmaceuticals (NASDAQ: ANIP) to $30.00 (from $40.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ANI Pharmaceuticals (ANIP) PT Lowered to $119 at Guggenheim
- ANI Pharmaceuticals (ANIP) PT Lowered to $90 at Canaccord
- Solar Industries (SOIL:IN) PT Raised to INR23,500 at ICICI Securities
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Cantor Fitzgerald, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
